FDA approves new painkiller that shows promise and challenges of opioid alternatives
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...
Breakthrough Victoria invests in Melbourne-based company ‘with a nose for innovation’
Independent investment company Breakthrough Victoria is investing $800,000 in Diag-Nose.io Medical (DNM), a Melbourne based ...